Effect of mitomycin-C on human retinal pigment epithelium in culture

被引:5
作者
Ho, TC
DelPriore, LV
Hornbeck, R
机构
[1] WASHINGTON UNIV,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,DEPT BIOCHEM & MOL BIOPHYS,ST LOUIS,MO 63110
[3] NATL TAIWAN UNIV HOSP,DEPT OPHTHALMOL,TAIPEI,TAIWAN
关键词
cell proliferation; mitomycin-C; proliferative vitreoretinopathy; human retinal pigment epithelium (HRPE);
D O I
10.1076/ceyr.16.6.572.5073
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To determine the effect of mitomycin-C on confluent and non-confluent human retinal pigment epithelium (RPE) in tissue culture. Methods. The effect of mitomycin-C on confluent RPE was determined by treating first passage confluent cells with 0.01, 0.1, 1, 10, 100 or 1000 micromolar (mu M) mitomycin-C for 1, 3. or 7 days. The cell viablility after treatment was determined by using an esterase stain. The effect of mitomycin-C on proliferating RPE was determined by incubating non-confluent cells with the above concentrations of mitomycin-C for 20 min, 1 hour or 24 hours. Results. Mitomycin-C can be toxic to a confluent RPE monolayer, and the LD50 is 421, 28.8 or 0.0632 mu M when cells are continually exposed to mitomycin-C for 1, 3 or 7 days, respectively. Exposure to mitomycin-C at concentrations greater than or equal to 10 mu M for 20-60 min significantly inhibits proliferation of non-confluent RPE. A 24 hour exposure of RPE to 1 mu M mitomycin-C markedly inhibits proliferation of non-confluent RPE with minimal toxicity to confluent RPE. Conclusions. Since exposure of human RPE to mitomycin-C for 24 hours can inhibit cell proliferation at concentrations which are well-tolerated by confluent RPE, mitomycin-C may be a suitable agent for inhibiting RPE proliferation in vivo.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 17 条
[1]  
BLUMENKRANZ M, 1984, OPHTHALMOLOGY, V91, P122
[2]   TRABECULECTOMY WITH SIMULTANEOUS TOPICAL APPLICATION OF MITOMYCIN-C IN REFRACTORY GLAUCOMA [J].
CHEN, CW ;
HUANG, HT ;
BAIR, JS ;
LEE, CC .
JOURNAL OF OCULAR PHARMACOLOGY, 1990, 6 (03) :175-182
[3]  
CHEN EP, 1992, INVEST OPHTH VIS SCI, V33, P2160
[4]   INFLUENCE OF MITOMYCIN-C ON ENDOTHELIAL MONOLAYER REGENERATION INVITRO [J].
COOMBER, BL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 50 (03) :293-300
[5]   MITOMYCIN-C - REVIEW [J].
CROOKE, ST ;
BRADNER, WT .
CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139
[6]   Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration [J].
DelPriore, LV ;
Kaplan, HJ ;
Hornbeck, R ;
Jones, Z ;
Swinn, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 122 (05) :629-643
[7]   TOXICITY OF MITOMYCIN-C TOWARD CULTURED PULMONARY-ARTERY ENDOTHELIUM [J].
HOORN, CM ;
WAGNER, JG ;
PETRY, TW ;
ROTH, RA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 130 (01) :87-94
[8]   5-MINUTE TREATMENTS WITH FLUOROURACIL, FLOXURIDINE, AND MITOMYCIN HAVE LONG-TERM EFFECTS ON HUMAN TENON CAPSULE FIBROBLASTS [J].
KHAW, PT ;
SHERWOOD, MB ;
MACKAY, SLD ;
ROSSI, MJ ;
SCHULTZ, G .
ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (08) :1150-1154
[9]   ANTIPROLIFERATIVE DRUGS IN THE TREATMENT OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY - CONTROL BY DAUNOMYCIN [J].
KIRMANI, M ;
SANTANA, M ;
SORGENTE, N ;
WIEDEMANN, P ;
RYAN, SJ .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1983, 3 (04) :269-272
[10]   TRABECULECTOMY WITH MITOMYCIN - A COMPARATIVE-STUDY WITH FLUOROURACIL [J].
KITAZAWA, Y ;
KAWASE, K ;
MATSUSHITA, H ;
MINOBE, M .
ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (12) :1693-1698